Indonesia bans Indian cough syrup material linked to Gambia child deaths

Published: Updated:
Enable Read mode
100% Font Size

Indonesia on Saturday banned ingredients linked to the deaths of 70 children in Gambia from cough syrups in the Southeast Asian country as it investigates acute kidney damage that has killed more than 20 children in the capital Jakarta this year.

Food and drug regulator BPOM also said it was investigating the possibility that the ingredients, diethylene glycol and ethylene glycol, had contaminated other materials that are used as solvents.


For the latest headlines, follow our Google News channel online or via the app.

Gambia and India are investigating the deaths from acute kidney injury in the west-African country thought to be linked to cough syrups made by New Delhi-based Maiden Pharmaceuticals Ltd.

The World Health Organization has said it found “unacceptable” levels of the ingredients, which can be toxic, in four Maiden products.

“To provide protection to the public, BPOM has set a requirement at the time of registration that all medicinal syrup products for children and adults are not allowed to use diethylene glycol (DEG) and ethylene glycol (EG),” the regulator said in a statement.

The BPOM reiterated that the four products linked to the deaths in Gambia are not registered in Indonesia, nor any other Maiden products.

Read more:

Indian state drug regulator orders sample checks on all oral liquid solutions: Report

WHO issues warning on Indian cough syrup linked to 66 Gambian child deaths

India finds violations in factory making cough syrup linked to Gambia deaths

Top Content Trending